Cemat A/S Unveils Managerial Share Transactions Update
Recent Managerial Transactions at Cemat A/S
Cemat A/S recently shared crucial updates regarding managerial transactions, highlighting a significant purchase by its chairman. Understanding these changes is important for investors and stakeholders who keep a close eye on the company's governance and market actions.
Details of Transactions
In compliance with Article 19 of the market abuse regulation, Cemat A/S disclosed vital information about a managerial transaction executed on a specific date. The transaction involved Frede Clausen, the Chairman of the Board of Directors.
Managerial Profile
Frede Clausen holds the influential position of Chairman at Cemat A/S. His decision to engage in transactions underlines a commitment to the company’s growth and development.
Transaction Overview
The conducted transaction involved the purchase of shares. The details are as follows:
Financial Instrument
The type of financial instrument involved in this particular transaction was shares, specifically identified by the ISIN DK0010271584. A purchase was executed at a price of DKK 525,000.00 for a total volume of 500,000 shares.
Aggregated Information
To encapsulate the transaction information:
- Aggregated Volume: 500,000 shares
- Price: DKK 525,000.00, translating to DKK 1.05 per share
Transaction Details
The transaction itself took place on a date designated as September 2, 2024, and was executed outside of a trading venue, indicated as XOFF. This contextualizes the nature of the transaction as being part of internal corporate governance rather than the public trading market.
Contact Information
For additional inquiries, reach out to:
Cemat A/S
Jaroslaw Pawel Lipinski
CEO
Frequently Asked Questions
What prompted the announcement of recent transactions?
Cemat A/S announced recent transactions as part of their regulatory requirement under market abuse regulation.
Who made the transactions?
The transactions were made by Frede Clausen, the Chairman of the Board of Directors at Cemat A/S.
What was the nature of the transaction?
The transaction involved the purchase of shares, amounting to a significant financial investment in the company.
What was the price and volume of the shares purchased?
The total volume of shares purchased was 500,000 at a price of DKK 1.05 per share.
How does this transaction impact shareholders?
This transaction can indicate a strong belief in the company’s future prospects, potentially reassuring shareholders about the leadership's confidence.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Planisware Reports Total Shares and Voting Rights Metrics
- Voltalia SA Share Capital Insights as of July 2024
- Alliance Trust PLC Updates Share Buyback Details Today
- U.S. Manufacturing Update: Signs of Recovery Amid Challenges
- Ademi LLP Investigates SPAR Group's Transaction Fairness for Shareholders
- Cargotec Corporation: Recent Share Repurchase News Update
- Nexity Monthly Update on Voting Rights and Share Capital
- Sodexo's Monthly Update on Share Capital and Voting Rights
- LVMH Discloses Share Transactions for Late August 2024
- Crown Aesthetics Unveils FDA-Cleared SkinPen Precision Elite
- Iveco Group Updates on Progress of Share Buyback Program
- HighCo Shareholding Update for August 2024
- Oil Market Update: Key Factors Affecting Major Stocks Today
- Hargreave Hale AIM VCT PLC Updates Net Asset Value Announcement
- Wipfli Unveils 2024 Annual Report Detailing Growth and Innovation
- Exdion Insurance Unveils CSRdigit: Revolutionizing E&O Protection
- Agmatix Unveils RegenIQ: Revolutionizing Regenerative Agriculture
- Trethom AS Reduces Major Shareholding in Vow ASA Below 5%
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
- Eton Solutions Unveils EtonGPT™, Revolutionary AI for Family Offices
- Cleartide Unveils Stylish and Efficient Condensate Pumps
- Middlefield Canadian Income PCC: Major Holdings Update
- Baker Hughes Unveils Leadership Changes for Future Growth
- Park Street A/S Announces Treasury Shares Update
- Borregaard ASA Reports Managerial Transactions in Shares
Recent Articles
- Exciting Growth in Medical Robotics Surgery Market Forecast
- Voltalia SA Share Capital Insights as of July 2024
- Vicor Corporation Addresses Recent Litigation Claims
- Packaging Automation Market Growth Driven by E-commerce Boom
- Cleartide Unveils Stylish and Efficient Condensate Pumps
- NXG NextGen Infrastructure Income Fund Announces New Distributions
- Argonaut Gold's Redemption of Convertible Debentures Announced
- Decisely Proudly Partners with Stewart-Haas Racing in NASCAR
- Industrial Automation Market to Reach USD 377.9 Billion by 2032
- Growing Demand for Pick to Light Solutions Transforming Industries
- Public Disclosure by Rathbones Group on Balanced Trust
- TEN, Ltd. Schedules Q2 2024 Results Event and Conference Call
- Caristo Diagnostics Recognized as a Quarterfinalist for Digital Health Award
- Semnur Pharmaceuticals and Denali Capital to Merge for Growth
- dxFeed Partners with PriceSquawk to Enhance Trading Experience
- PTC Welcomes Rob Bernshteyn to the Board of Directors
- The Chefs' Warehouse Engages in CL King's Best Ideas Conference
- NCL Corporation Ltd. Proposes Offering of Senior Notes
- Risk Mitigation Consulting Secures Key U.S. Marine Corps Contract
- Ecopetrol S.A. Board Resignation and Corporate Decisions Update
- Unicycive Therapeutics Submits NDA for Oxylanthanum Carbonate
- Piston Air Motors Market Projects Growth to $987 Million by 2034
- Viracta Therapeutics to Showcase Innovations at Conference
- PolyPid Announces Participation in Key Fall Investor Events
- Medical Properties Trust Navigates Challenges with New Deal